Advanced search
Publication Cover
Acta Orthopaedica Volume 90, 2019 - Issue 2
Journal homepage
2,826
Views
12
CrossRef citations to date
0
Altmetric
Articles

Target site antibiotic concentrations in orthopedic/trauma extremity surgery: is prophylactic cefazolin adequately dosed? A systematic review and meta-analysis

Fay R K SandersTrauma Unit, Department of Surgery, Amsterdam UMC, University of Amsterdam;;
,
J Carel GoslingsDepartment of Surgery, OLVG, Amsterdam;
,
Ron A A MathôtDepartment of Hospital Pharmacy, Amsterdam UMC, University of Amsterdam, the Netherlands
&
Tim SchepersTrauma Unit, Department of Surgery, Amsterdam UMC, University of Amsterdam;; Correspondence[email protected]
Pages 97-104 | Published online: 11 Feb 2019

  • Agodi A, Auxilia F, Barchitta M, Cristina M L, D’Alessandro D, Mura I, Nobile M, Pasquarella C, GISIO-SItI. Risk of surgical site infections following hip and knee arthroplasty: results of the ISChIA-GISIO study. Ann DI Ig Med Prev E DI Comunita 2017; 29(5): 422–30.
  • AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 2008; 90(7): 915–19.
  • Angthong C, Krajubngern P, Tiyapongpattana W, Pongcharoen B, Pinsornsak P, Tammachote N, Kittisupaluck W. Intraosseous concentration and inhibitory effect of different intravenous cefazolin doses used in preoperative prophylaxis of total knee arthroplasty. J Orthop Traumatol 2015; 16(4): 331–4.
  • Backes M, Schepers T, Beerekamp M S H, Luitse J S K, Goslings J C, Schep N W L. Wound infections following open reduction and internal fixation of calcaneal fractures with an extended lateral approach. Int Orthop 2014; 38(4): 767–73.
  • Bauer M P, van de Garde E M W, van Kasteren M E E, Prins J, Vos M. SWAB Richtlijn: [peri-operatieve profylaxe. [Dutch] 2017; (January): 1–10.
  • Borenstein M, Hedges L V, Higgins J P T, Rothstein H R. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010; 1(2): 97–111.
  • Boxma H, Broekhuizen T, Patka P, Oosting H. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet 1996; 347(9009): 1133–7.
  • Bratzler D W, Dellinger E P, Olsen K M, Perl T M, Auwaerter P G, Bolon M K, Fish D N, Napolitano L M, Sawyer R G, Slain D, Steinberg J P, Weinstein R A. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Heal Pharm 2013; 70(3): 195–283.
  • Brill M J E, Houwink A P I, Schmidt S, Van Dongen E P A, Hazebroek E J, Van Ramshorst B, Deneer V H, Mouton J W, Knibbe C A J. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. J Antimicrob Chemother 2014; 69(3): 715–23.
  • Bryan C S, Morgan S L, Caton R J, Lunceford E M. Cefazolin versus cefamandole for prophylaxis during total joint arthroplasty. Clin Orthop Relat Res 1988; (228): 117–22.
  • Burke J F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161–8.
  • Burnett J W, Gustilo R B, Williams D N, Kind A C. Prophylactic antibiotics in hip fractures: a double-blind, prospective study. J Bone Joint Surg Ser A 1980; 62(3): 457–62.
  • Cunha B A, Gossling H R, Pasternak H S, Nightingale C H, Quintiliani R. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg Am 1977; 59(7): 856–9.
  • Cunha B A, Gossling H R, Pasternak H S, Nightingale C H, Quintiliani R. Penetration of cephalosporins into bone. Infection 1984; 12(2): 80–4.
  • Deacon J S, Wertheimer S J, Washington J A. Antibiotic prophylaxis and tourniquet application in podiatric surgery. J Foot Ankle Surg 1996; 35(4): 344–9.
  • De Jong L, Klem T M A L, Kuijper T M, Roukema G R. Factors affecting the rate of surgical site infection in patients after hemiarthroplasty of the hip following a fracture of the neck of the femur. Bone Joint J 2017; 99B(8): 1088–94.
  • Feilmeier M, Dayton P, Sedberry S, Reimer R A. Incidence of surgical site infection in the foot and ankle with early exposure and showering of surgical sites: a prospective observation. J Foot Ankle Surg 2014; 53(2): 173–5.
  • Friedman R J, Friedrich L, White R L, Kays M B, Brundage D M, Graham J. Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty. Clin Orthop Relat Res 1990; (260): 17–23.
  • Gergs U, Clauss T, Ihlefeld D, Weiss M, Pönicke K, Hofmann G O, Neumann J. Pharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery. J Pharm Pharmacol 2014; 66(11): 1552–8.
  • Higgins J P T, Thompson S G, Spiegelhalter D J. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009; 172(1): 137–59.
  • Hozo S P, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.
  • Mangram A J, Horan T C, Pearson M L, Silver L C, Jarvis W R. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20(4): 250–78; quiz 279-80.
  • Miller B S, Harper W P, Hughes J S, Sonnabend D H, Walsh W R. Regional antibiotic prophylaxis in elbow surgery. J Shoulder Elb Surg 2004; 13(1): 57–9.
  • Moher D, Liberati A, Tetzlaff J, Altman D G, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339(17): b2535.
  • Moine P, Fish D N. Pharmacodynamic modelling of intravenous antibiotic prophylaxis in elective colorectal surgery. Int J Antimicrob Agents 2013; 41(2): 167–73.
  • Mouton J W, Theuretzbacher U, Craig W A, Tulkens P M, Derendorf H, Cars O. Tissue concentrations: do we ever learn? J Antimicrob Chemother 2008; 61(2): 235–7.
  • Müller M, Dela Peña A, Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob. Agents Chemother 2004; 48(5): 1441–53.
  • Parsons R L, Beavis J P, David J A, Paddock G M, Trounce J R. Plasma, bone, hip capsule, and drain fluid concentrations of cephazolin during total hip replacement. Br J Clin Pharmac 1978; 5: 331–6.
  • Partlett C, Riley R D. Random effects meta-analysis: coverage performance of 95% confidence and prediction intervals following REML estimation. Stat Med 2017; 36(2): 301–17.
  • Polk R, Hume A, Kline B J, Cardea J. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion. Clin Orthop Relat Res 1983; 177(7): 216–21.
  • Sharareh B, Sutherland C, Pourmand D, Molina N, Nicolau D P, Schwarzkopf R. Effect of body weight on cefazolin and vancomycin trabecular bone concentrations in patients undergoing total joint arthroplasty. Surg Infect (Larchmt) 2016; 17(1): 71–7.
  • Sørensen T S, Colding H, Schroeder E, Rosdahl V T. The penetration of cefazolin, erythromycin and methicillin into human bone tissue. Acta Orthop 1978; 49(6): 549–53.
  • Voigt J, Mosier M, Darouiche R. Systematic review and meta-analysis of randomized controlled trials of antibiotics and antiseptics for preventing infection in people receiving primary total hip and knee prostheses. Antimicrob Agents Chemother 2015; 59(11): 6696–707.
  • Wells G A, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hosp Res Inst 2013; (3): 1–4.
  • Wiewiorski M, Barg A, Hoerterer H, Voellmy T, Henninger H B, Valderrabano V. Risk factors for wound complications in patients after elective orthopedic foot and ankle surgery. Foot Ankle Int 2015; 36(5): 479–87.
  • Williams D N, Gustilo R B, Beverly R, Kind A C. Bone and serum concentrations of five cephalosporin drugs: relevance to prophylaxis and treatment in orthopedic surgery. Clin Orthop Relat Res 1983; (179): 253–65.
  • Yamada K, Matsumoto K, Tokimura F, Okazaki H, Tanaka S. Are bone and serum cefazolin concentrations adequate for antimicrobial prophylaxis? Clin Orthop Relat Res 2011; 469(12): 3486–94.
  • Young S W, Zhang M, Freeman J T, Vince K G, Coleman B. Higher cefazolin concentrations with intraosseous regional prophylaxis in TKA knee. Clin Orthop Relat Res 2013; 471(1): 244–9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.